Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron

1 Views
administrator
administrator
06/15/23

A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next